These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 4428784)

  • 1. [Modification of disordered coronary and peripheral circulation using essential phospholipids].
    Pristautz H; Pavek P; Klein W
    Wien Med Wochenschr; 1974 Nov; 124(44):644-8. PubMed ID: 4428784
    [No Abstract]   [Full Text] [Related]  

  • 2. [The therapeutic value of "Essential" phospholipids].
    Pristautz H
    MMW Munch Med Wochenschr; 1975 Apr; 117(14):583-6. PubMed ID: 806790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of the administration of exogenous phospholipids in dyslipidemic patients].
    Ravielle A; Delise P; Totaro G; Piccolo E
    Clin Ter; 1978 Sep; 86(5):441-9. PubMed ID: 737968
    [No Abstract]   [Full Text] [Related]  

  • 4. [Action of "essential" phospholipids on plasma lipids and fatty acids in type II hyperlipoproteinemias].
    Peeters H; Blaton V; Soetewey F; Declercq B; Vandamme D
    Munch Med Wochenschr; 1973 Aug; 115(31):1358-62. PubMed ID: 4741079
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on the effect of essential phospholipids in the essential hypertriglyceridemia].
    Walther M; Unger E; Jaross W; Hanefeld M
    Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:182-4. PubMed ID: 5402583
    [No Abstract]   [Full Text] [Related]  

  • 6. [On some aspects of the dynamics of post-alimentary lipid transport following the intravenous administration of essential phospholipids].
    Pedini G; Gherson G
    Clin Ter; 1967 Oct; 43(1):49-72. PubMed ID: 5605580
    [No Abstract]   [Full Text] [Related]  

  • 7. [Relations between primary hyperlipoproteinemia and cardiovascular diseases from geriatric aspects].
    Reuter W
    Z Arztl Fortbild (Jena); 1977 Jan; 71(2):62-5. PubMed ID: 848050
    [No Abstract]   [Full Text] [Related]  

  • 8. [Essential phopholipids and hypertriglyceridemia due to a high carbohydrate diet].
    Pedini G
    Minerva Med; 1970 Mar; 61(23):1113-28. PubMed ID: 5436724
    [No Abstract]   [Full Text] [Related]  

  • 9. [Studies of peripheal circulation by impedance plethysmography during anesthesia. 3. Effects of hypothermia on peripheral circulation during cardiovascular sugery].
    Ikeda T
    Masui; 1968 Aug; 17(8):749-63. PubMed ID: 5750546
    [No Abstract]   [Full Text] [Related]  

  • 10. Platelet function and platelet phospholipids in patients with hyperbetalipoproteinemia. Effect of nicotinic acid and clofibrate.
    Nordoy A; Rodset JM
    Acta Med Scand; 1971 May; 189(5):385-9. PubMed ID: 5578488
    [No Abstract]   [Full Text] [Related]  

  • 11. [Essential hyperlipoproteinemia type IV (essential endogenous hypertriglyceridemia); clinical and laboratory investigation in 11 patients and their families].
    Jelić S; Rosić D; Bojović I; Bojić P
    Srp Arh Celok Lek; 1978; 106(7-8):717-36. PubMed ID: 752953
    [No Abstract]   [Full Text] [Related]  

  • 12. [Tiadenol in the treatment of primary hyperlipidemias].
    Liguori A; Sibilio G; Mastursi M; Tarzia R; Casale A; Pellegrino G; Varriale A
    G Clin Med; 1981 Jan; 62(1):51-64. PubMed ID: 7227710
    [No Abstract]   [Full Text] [Related]  

  • 13. [Essential hyperlipemia and acute pancreatitis].
    Braunsteiner H; Herbst M; Sailer S; Sandhofer F
    Schweiz Med Wochenschr; 1967 Jun; 97(22):698-702. PubMed ID: 5592575
    [No Abstract]   [Full Text] [Related]  

  • 14. Reducing drug usage and adverse effects. Part III: Cardiovascular disease and hyperlipidemia.
    Baron M
    Health Care Food Nutr Focus; 2005 Jun; 22(6):7-11. PubMed ID: 15923907
    [No Abstract]   [Full Text] [Related]  

  • 15. Lipid profiles in the Isfahan population: an Isfahan cardiovascular disease risk factor survey, 1994.
    Rafiei M; Boshtam M; Sarraf-Zadegan N
    East Mediterr Health J; 1999 Jul; 5(4):766-77. PubMed ID: 11338699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents.
    Dupuy AM; Carrière I; Scali J; Cristol JP; Ritchie K; Dartigues JF; Gambert P; Ancelin ML
    Climacteric; 2008 Feb; 11(1):74-83. PubMed ID: 18202967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A low-risk substance for the lowering of reused levels of blood lipids].
    Berg H
    Fortschr Med; 1981 Feb; 99(7):236-40. PubMed ID: 7216108
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of primitive hyperlipidemias with a tetralin derivative].
    Fellin R; Fedele D; Bagnariol G; Pagnan A; Crepaldi G
    G Ital Cardiol; 1972; 2(6):863-70. PubMed ID: 4564549
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug therapy for hyperlipidemia.
    Franklin FA; Margolis S
    Cardiovasc Clin; 1984; 14(3):265-84. PubMed ID: 6722855
    [No Abstract]   [Full Text] [Related]  

  • 20. Lipid profiles.
    Winder T
    Br J Hosp Med; 1994 Feb 2-15; 51(3):102-4. PubMed ID: 8193830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.